3CPLro-IN-1 (compound A17) is a potent, orally active inhibitor of SARS-CoV-2 3-Chymotrypsin-like cysteine protease (3CLpro) with an IC50 of 5.65 µM, making it an attractive drug target against COVID-19 and also considered an antitumor agent-51.
Molecular Weight:
435.51
CAS Number:
[2432956-06-2]
Formula:
C29H25NO3
Target:
SARS-CoV|||Others
T62479
* VAT and and shipping costs not included. Errors and price changes excepted